Kirilys Therapeutics
Kirilys Therapeutics is a multi-asset precision oncology company developing targeted therapeutic treatments for cancer patients. Led by co-founder and CEO BT Slingsby, MD, PhD, MPH, the company is building a pipeline of precision medicines and is backed by Catalys Pacific, Lightspeed Venture Partners, and UBE. Kirilys was surfaced as a portfolio company of Lightspeed Venture Partners and added to the API Evangelist network. As a clinical-stage biotech, Kirilys publishes a corporate marketing website (company, news, and contact pages) but exposes no public developer API, SDK, documentation, or machine discovery surface at this time.
Kirilys Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Therapeutics, Oncology, Biotechnology, and Pharmaceuticals.
Kirilys Therapeutics’ developer surface includes product news, engineering blog, support, and 4 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API